Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients.
Ver gráficos interactivos y estados completos →
| Cuenta de resultados | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Ingresos totales | ₹137.5B | ₹113.2B | ₹105.6B | ₹94.6B |
| Beneficio bruto | ₹102.3B | ₹84.3B | ₹77.7B | ₹66.4B |
| Ingresos operativos (EBIT) | ₹34.4B | ₹29.3B | ₹25.7B | ₹21.4B |
| Ingresos netos | ₹21.6B | ₹19.1B | ₹16.6B | ₹12.5B |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de TORNTPHARM. /companies/us/TORNTPHARM
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms